These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 7055686)
1. Oxygen dependence of dopamine-beta-hydoxylase activity and lactate metabolism in synaptosomes from rat brain. Katz IR Brain Res; 1982 Jan; 231(2):399-409. PubMed ID: 7055686 [TBL] [Abstract][Full Text] [Related]
2. Oxygen dependence of glucose and acetylcholine metabolism in slices and synaptosomes from rat brain. Ksiezak HJ; Gibson GE J Neurochem; 1981 Aug; 37(2):305-14. PubMed ID: 7264662 [TBL] [Abstract][Full Text] [Related]
3. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699 [TBL] [Abstract][Full Text] [Related]
4. Threshold requirements for oxygen in the release of acetylcholine from, and in the maintenance of the energy state in, rat brain synaptosomes. Park IR; Thorn MB; Bachelard HS J Neurochem; 1987 Sep; 49(3):781-8. PubMed ID: 3612124 [TBL] [Abstract][Full Text] [Related]
5. Effects of in vitro anoxia and low pH on acetylcholine release by rat brain synaptosomes. Sanchez-Prieto J; Harvey SA; Clark JB J Neurochem; 1987 Apr; 48(4):1278-84. PubMed ID: 3819730 [TBL] [Abstract][Full Text] [Related]
6. Isolation of monoaminergic synaptosomes from rat brain by immunomagnetophoresis. Docherty M; Bradford HF; Cash CD; Ehret M; Maitre M; Joh TH J Neurochem; 1991 May; 56(5):1569-80. PubMed ID: 1672882 [TBL] [Abstract][Full Text] [Related]
7. Evidence for inhibition of dopamine-beta-hydroxylase in vivo after sub-acute pyrazole treatment in rats. MacDonald E; Pispa JP Med Biol; 1977 Oct; 55(5):284-91. PubMed ID: 22792 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of type A and type B monoamine oxidase inhibitors on synaptosomal accumulation of [3H]dopamine: a reflection of antidepressant potency. Azzaro AJ; Demarest KT Biochem Pharmacol; 1982 Jun; 31(12):2195-7. PubMed ID: 7115440 [No Abstract] [Full Text] [Related]
9. The mechanism by which monoamine oxidase inhibitors give rise to a non-calcium-dependent component in the depolarization-induced release of 5-HT from rat brain synaptosomes. Evans SM; Collard KJ Br J Pharmacol; 1988 Nov; 95(3):950-6. PubMed ID: 3264736 [TBL] [Abstract][Full Text] [Related]
10. [Synaptosomal transport of cerebral tryptophan and tyrosine. Stimulation of the rate of uptake after administration of reserpine or monoamine oxidases inhibitor]. Belin MF; Chouvet G; Pujol JF Biochem Pharmacol; 1974 Feb; 23(3):587-97. PubMed ID: 4822744 [No Abstract] [Full Text] [Related]
11. Pharmacology of amezinium, a novel antihypotensive drug. IV. Biochemical investigations of the mechanism of action. Traut M; Brode E; Hoffmann HD Arzneimittelforschung; 1981; 31(9a):1566-74. PubMed ID: 7197971 [TBL] [Abstract][Full Text] [Related]
12. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes. Bowyer JF; Spuhler KP; Weiner N J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652 [TBL] [Abstract][Full Text] [Related]
13. [Effect of MAO inhibitors on impeding synaptosomal withdrawal and on dopamine metabolism in rat and human brain]. Tóthfalusi L; Tekes K; Gaál J; Magyar K Acta Pharm Hung; 1989; 59 Suppl 1():75-9. PubMed ID: 2641638 [No Abstract] [Full Text] [Related]
14. [Effect of reserpine on monoamine uptake by rat brain synaptosomes]. Blaschke M; Fischer HD; Rudolph E Acta Biol Med Ger; 1980; 39(11-12):1205-12. PubMed ID: 7245989 [TBL] [Abstract][Full Text] [Related]
15. Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport. Zaczek R; Culp S; De Souza EB J Pharmacol Exp Ther; 1991 May; 257(2):830-5. PubMed ID: 1903446 [TBL] [Abstract][Full Text] [Related]
16. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum. Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766 [TBL] [Abstract][Full Text] [Related]
17. Release of synaptosomal dopamine formed from tyrosine and L-DOPA. Bagchi SP; Bagchi P; Smith TM Brain Res; 1980 Apr; 187(2):403-14. PubMed ID: 7370738 [TBL] [Abstract][Full Text] [Related]
18. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine. Tissari AH Med Biol; 1982 Feb; 60(1):38-41. PubMed ID: 6121960 [TBL] [Abstract][Full Text] [Related]
19. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Clarke PB; Reuben M Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402 [TBL] [Abstract][Full Text] [Related]
20. Na(+)-Ca2+ exchange activity in central nerve endings. II. Relationship between pharmacological blockade by amiloride analogues and dopamine release from tuberoinfundibular hypothalamic neurons. Taglialatela M; Canzoniero LM; Cragoe EJ; Di Renzo G; Annunziato L Mol Pharmacol; 1990 Sep; 38(3):393-400. PubMed ID: 2402228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]